Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Get Started

ABMD

ABIOMED (ABMD)

ABIOMED Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ABMD

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
01/06/2023	6:40AM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ABMD	ABIOMED Inc
01/03/2023	8:31AM	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:ABMD	ABIOMED Inc
12/27/2022	5:56PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ABMD	ABIOMED Inc
12/27/2022	5:47PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ABMD	ABIOMED Inc
12/27/2022	5:30PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ABMD	ABIOMED Inc
12/27/2022	5:28PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ABMD	ABIOMED Inc
12/27/2022	5:20PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ABMD	ABIOMED Inc
12/22/2022	4:47PM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ABMD	ABIOMED Inc
12/22/2022	4:46PM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ABMD	ABIOMED Inc
12/22/2022	4:46PM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ABMD	ABIOMED Inc
12/22/2022	4:41PM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ABMD	ABIOMED Inc
12/22/2022	4:41PM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ABMD	ABIOMED Inc
12/22/2022	4:40PM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ABMD	ABIOMED Inc
12/22/2022	4:39PM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ABMD	ABIOMED Inc
12/22/2022	4:39PM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ABMD	ABIOMED Inc
12/22/2022	4:38PM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ABMD	ABIOMED Inc
12/22/2022	4:38PM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ABMD	ABIOMED Inc
12/22/2022	4:37PM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ABMD	ABIOMED Inc
12/22/2022	4:35PM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ABMD	ABIOMED Inc
12/22/2022	4:34PM	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ABMD	ABIOMED Inc
12/22/2022	4:33PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ABMD	ABIOMED Inc
12/22/2022	9:15AM	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:ABMD	ABIOMED Inc
12/22/2022	9:01AM	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:ABMD	ABIOMED Inc
12/22/2022	8:51AM	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:ABMD	ABIOMED Inc
12/21/2022	5:33PM	Business Wire	La FDA approuve la pompe cardiaque Impella ECP et les premiers patients sont recrutés dans un essai clinique pivot	NASDAQ:ABMD	ABIOMED Inc
12/21/2022	5:13PM	Business Wire	Impella ECP-Herzpumpe erhält FDA-Zulassung – erste Patienten in zulassungsrelevante klinische Studie aufgenommen	NASDAQ:ABMD	ABIOMED Inc
12/21/2022	9:00AM	Business Wire	FDA Approves Impella ECP Pivotal Heart Pump and First Patients Enrolled in Pivotal Clinical Trial	NASDAQ:ABMD	ABIOMED Inc
12/20/2022	4:06PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ABMD	ABIOMED Inc
12/20/2022	4:03PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ABMD	ABIOMED Inc
12/19/2022	6:35PM	PR Newswire (US)	Steel Dynamics Set to Join S&P 500; Super Micro Computer to Join S&P MidCap 400	NASDAQ:ABMD	ABIOMED Inc